Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE004102 |
ID: | TCMBANKHE004102 |
植物拉丁名: |
|
功能与主治: | See Codonopsis pilosula./See Codonopsis pilosula . |
药用植物名: | 川党参 |
药用部位: | root |
TCM_ID_id: | 6128 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000445 | hexyl amine-1 | C6H15N | 101.19 g/mol | CCCCCCN | |
| TCMBANKIN001435 | Codopiloic acid | codopiloic acid; codopiloicacid; 136945-75-0; 2H-1,4-oxazine-3-carboxylic acid | C5H5NO3 | 127.1 | C1C(=NC=CO1)C(=O)O |
| TCMBANKIN001607 | Coelogin | CHEBI:3806; DTXSID50331912; 82358-31-4; C10251; AC1L9D92; coelogin | C17H16O5 | 300.31 | COC1=C(C(=C2COC3=CC(=CC4=C3C2=C1CC4)O)O)OC |
| TCMBANKIN008729 | hexyl-β-d-glucopyranosyl-(1→6)-β-d-gluco-pyranoside | C18H34O11 | |||
| TCMBANKIN010277 | Perlolyrine | [5-(9H-pyrido[3,4-b]indol-1-yl)-2-furyl]methanol; InChI=1/C16H12N2O2/c19-9-10-5-6-14(20-10)16-15-12(7-8-17-16)11-3-1-2-4-13(11)18-15/h1-8,18-19H,9H; 2-Furanmethanol, 5-(9H-pyrido(3,4-b)indol-1-yl)-; [5-(9H-pyrido[3,4-b]indol-1-yl)furan-2-yl]methanol; CCRIS 4068; [5-(9H-$b-carbolin-1-yl)-2-furyl]methanol; 29700-20-7; 2-Dehydrocarbonylflazin; perlolyrine; 100041-67-6; C09231; [5-(9H-Beta-carbolin-1-yl)-2-furyl]methanol | C16H12N2O2 | 264.28 | C1=CC=C2C(=C1)C3=C(N2)C(=NC=C3)C4=CC=C(O4)CO |
| TCMBANKIN015711 | 6,6-dimethyl-2-methylene-7-(3-oxobutylidene)oxepan-3-ylmethyl acetic acid ester | 280.4 | |||
| TCMBANKIN021797 | Codonopsine | codonopsine; C10137; AC1L9D48; (2R,3R,4R,5R)-2-(3,4-dimethoxyphenyl)-1,5-dimethylpyrrolidine-3,4-diol; CHEBI:3805; NCGC00160242-01; DTXSID60331887; 26989-20-8; (2R,3R,4R,5R)-2-(3,4-dimethoxyphenyl)-1,5-dimethyl-pyrrolidine-3,4-diol; STOCK1N-18670 | C14H21NO4 | 267.32 | CC1C(C(C(N1C)C2=CC(=C(C=C2)OC)OC)O)O |
| TCMBANKIN022009 | taraxerone | Taraxerone | C30H48O | 424.7 g/mol | CC1(CCC2(CC=C3C4(CCC5C(C(=O)CCC5(C4CCC3(C2C1)C)C)(C)C)C)C)C |
| TCMBANKIN023626 | phenylalanine | ZB003544; 2S-alpha-phenylalanine; L-phenylalanine zwitterion; (2S)-2-azaniumyl-3-phenylpropanoate; CHEBI:58095; CJ-00758; AC1OBQNX; Phenyl alanine; (2S)-2-ammonio-3-phenylpropanoate | C9H11NO2 | 165.19 g/mol | C1=CC=C(C=C1)CC(C(=O)[O-])[NH3+] |
| TCMBANKIN025505 | tartaric acid | tartaricacid; LS-188035 | C4H6O6 | 150.09 g/mol | C(C(C(=O)O)O)(C(=O)O)O |
| TCMBANKIN030424 | methionine | 4eg4; (2S)-2-azaniumyl-4-methylsulfanyl-butanoate; 4eg7; (2S)-2-ammonio-4-(methylsulfanyl)butanoate; 3f3d; (2S)-2-azaniumyl-4-(methylsulfanyl)butanoate; (2S)-2-ammonio-4-(methylthio)butanoate; CJ-24201; A834471; L-methionine zwitterion; 4ega; CHEBI:57844; 4eg6; 4eg5; CJ-05251; 3tun | C5H11NO2S | 149.21 g/mol | CSCCC(C(=O)O)N |
| TCMBANKIN031402 | 2'- hexyl- 11'- United cyclopropane-2-- caprylic | ||||
| TCMBANKIN032303 | hexyl-β-d-glucopyranosyl-(1→2)-β-d-gluco-pyranoside | C18H34O11 | |||
| TCMBANKIN034825 | methionine sulfoxide | C5H11NO3S | 165.21 g/mol | CS(=O)CCC(C(=O)O)N | |
| TCMBANKIN036951 | Tanshilactone | tanshilactone | C17H12O3 | 264.28 | CC1=CC=CC2=C1C=CC3=C2C(=O)OC4=C3OC=C4C |
| TCMBANKIN040933 | 7-(beta-Xylosyl)cephalomannine | 7-(β-xylosyl)cephalomannine; 7-(beta-xylosyl)cephalomannine | C51H63NO17 | 962.15 | [C@@]1([H])(OC(=O)C([H])([H])[H])C(=C(C([H])([H])[H])[C@]([H])(OC(=C([H])[H])[C@]([H])(O[H])[C@@]([H])(N([H])C(=O)\C(=C([H])\C([H])([H])[H])\C([H])([H])[H])c2c([H])c([H])c([H])c([H])c2[H])C3([H])[H])C (C([H])([H])[H])(C([H])([H])[H])[C@]3(O[H])[C@]([H])(OC(c4c([H])c([H])c([H])c([H])c4[H])=O)[C@]([H])([C@@]5(OC(=O)C([H])([H])[H])[C@]([H])(OC5([H])[H])C([H])([H])[C@@]6(O[C@]7([H])OC([H])([H])[C@]([H] )(O[H])[C@]([H])(O[H])[C@@]7([H])O[H])[H])[C@]6(C([H])([H])[H])C1=O |
| TCMBANKIN041787 | tangshenoside III | tangshenoside iii | C34H46O17 | 726.7 g/mol | COC1=CC(=CC(=C1OC2C(C(C(C(O2)CO)O)O)O)OC)C=CCC3=C(C(=C(C=C3C=CCO)OC)OC4C(C(C(C(O4)CO)O)O)O)OC |
| TCMBANKIN041998 | (E)-2-Hexenyl-beta-D-glucopyranoside | (e)-2-hexenyl-β-d-glucopyranoside | C12H22O6 | 262.299 | O(C([H])([H])C([H])([H])\C([H])=C(\C([H])([H])C([H])([H])[H])[H])[C@@]1([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O1 |
| TCMBANKIN043969 | Tangshenoside II | AC1NT0OW; (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[4-(1-hydroxyprop-2-enyl)-2,6-dimethoxyphenoxy]oxane-3,4,5-triol; tangshenoside ii | C17H24O9 | 372.4 g/mol | COC1=CC(=CC(=C1OC2C(C(C(C(O2)CO)O)O)O)OC)C(C=C)O |
| TCMBANKIN044129 | (e)-2-hexenyl-beta-d-glucopyranosyl-(1-2)-beta-d-glucopyranoside | C18H32O11 | |||
| TCMBANKIN045407 | (E)-2-Hexenyl-α-L-arabinopyranosyl-(1→2)-β-D-glucopyranoside | ||||
| TCMBANKIN046658 | glycitein | C14536; 7-Hydroxy-3-(4-hydroxyphenyl)-6-methoxy-4H-1-benzopyran-4-one; ST5331727; 7-hydroxy-3-(4-hydroxyphenyl)-6-methoxy-4-chromenone; 7-hydroxy-3-(4-hydroxyphenyl)-6-methoxychromen-4-one; 4H-1-Benzopyran-4-one, 7-hydroxy-3-(4-hydroxyphenyl)-6-methoxy-; 7-hydroxy-3-(4-hydroxyphenyl)-6-methoxy-chromone; 40957-83-3; 7,4'-Dihydroxy-6-methoxyisoflavone; Glycitein; 7-hydroxy-3-(4-hydroxyphenyl)-6-methoxy-chromen-4-one | C16H12O5 | 284.263 | C([H])([H])([H])Oc1c([H])c(C(C(c2c([H])c([H])c(O[H])c([H])c2[H])=C([H])O3)=O)c3c([H])c1O[H] |
| TCMBANKIN046968 | fritillaziebinol | Fritillaziebinol | ClO | 324.98 | CC1(CCCC2(C1CCC34C2CCC(C3)C(C4)(CCl)O)C)C |
| TCMBANKIN047207 | hexyl-beta-d-glucopyranosyl-(1-6)-beta-d-glucopyranoside | C18H34O11 | 384.376 | ||
| TCMBANKIN048054 | taraxeryl acetate | C32H52O2 | 468.8 g/mol | CC(=O)OC1CCC2(C(C1(C)C)CCC3(C2CCC4(C3=CCC5(C4CC(CC5)(C)C)C)C)C)C | |
| TCMBANKIN048081 | (z)-3-hexenyl-beta-d-glucopyranoside | (z)-3-hexenyl-β-d-glucopyranoside | C12H22O6 | 262.3 g/mol | CCC=CCCOC1C(C(C(C(O1)CO)O)O)O |
| TCMBANKIN048371 | tangshenoside I | AC1O5UVU; Tangshenoside I; tangshenoside i; 117278-74-7; AK687051; beta-D-Glucopyranoside, 4-(3-(4-carboxy-3-(beta-D-glucopyranosyloxy)-3-methyl-1-oxobutoxy)-1-propenyl)-2,6-dimethoxyphenyl, (S-(E))-; 5-[(E)-3-[3,5-dimethoxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]prop-2-enoxy]-3-methyl-5-oxo-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentanoic acid; AKOS032945999 | C30H44O17 | 677 | c1([H])c(OC([H])([H])[H])c(O[C@]2([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]2([H])O[H])c(OC([H])([H])[H])c([H])c1\C([H])=C([H])\C([H])([H])OC(=O)C([H])([H])[C@](C([H])([H])[C@ ]3([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]3([H])O[H])(C([H])([H])[H])C([H])([H])C(=O)O[H] |
| TCMBANKIN049240 | (e)-2-hexenyl-β-d-glucopyranosyl-(1→2)-β-d-glucopyranoside | C18H32O11 | |||
| TCMBANKIN049318 | tangshenoside IV | tangshenoside iv | C46H64O26 | 1033 | C(O[H])(=O)C([H])([H])[C@](C([H])([H])[H])(O[C@]1([H])[C@@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@]([H])(C([H])([H])O[H])O1)C([H])([H])C(OC([H])([H])\C([H])=C([H])\c2c([H])c(OC([H])([H])[H])c(O[ C@]3([H])[C@@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@]([H])(C([H])([H])O[H])O3)c(OC([H])([H])[H])c2C([H])([H])\C([H])=C([H])\c4c([H])c(OC([H])([H])[H])c(O[C@@]5([H])[C@]([H])(O[H])[C@@]([H])(O[H ])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O5)c(OC([H])([H])[H])c4[H])=O |
| TCMBANKIN050348 | dehydrodiconiferyl alcohol | C20H22O6 | 358.385 | c1([H])c([H])c([C@@]2([H])[C@]([H])(C([H])([H])O[H])c(c([H])c(\C([H])=C([H])\C([H])([H])O[H])c([H])c3OC([H])([H])[H])c3O2)c([H])c(OC([H])([H])[H])c1O[H] | |
| TCMBANKIN057923 | glycin | Tocris-0219; G5417_SIGMA; WLN: Z1VQ; LS-218; 56-40-6; Glycosthene; G7126_SIGMA; Hgly; Glycine-UL-14C hydrochloride; EINECS 200-272-2; Padil; Polyglycine II; AB-131/40217813; Acido aminoacetico [INN-Spanish]; Glycine [INN]; G7403_SIGMA; CCRIS 5915; GLY (IUPAC abbrev); W328707_ALDRICH; Glycine-2-3H; G3649_SIGMA; InChI=1/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5; Glycine iron sulphate (1:1); NSC 25936; P8791_SIGMA; Leimzucker; Gyn-Hydralin; D00011; Aminoessigsaeure; 50046_FLUKA; Acidum aminoaceticum [INN-Latin]; Aminoethanoic acid; aminoacetic acid; AI3-04085; 33242-26-1; H2N-CH2-COOH; C00037; G8898_SIGMA; Glyzin; G0398_SIGMA; Amitone; Hampshire glycine; Glycocoll; G5523_SIGMA; Acide aminoacetique [INN-French]; Glycine-carboxy-14C hydrochloride; Glicina [INN-Spanish]; Glycinum [INN-Latin]; Glykokoll; ST5213923; 15527_RIEDEL; 7490-95-1; NChemBio.2007.13-comp1; Glycine, non-medical; BPBio1_001222; Biomol-NT_000195; 57678-19-0; Glycolixir; 63183-41-5; 87867-94-5; HSDB 495; AIDS071643; FEMA No. 3287; CHEBI:15428; 33226_RIEDEL; Sucre de gelatine; 17829-66-2; 410225_SIAL; NCGC00024503-01; 2-Aminoacetic acid; Aminoazijnzuur; NSC25936; Glycine (JP15/USP); polyglycine; 52955-63-2; carbonocyanidic acid; 32817-15-5; 2-aminoethanoic acid; Aciport; L-Glycine; Glicoamin; 25718-94-9; Acetic acid, amino-; G8790_SIGMA; AIDS-071643; NCGC00024503-02; Glycine, homopolymer (VAN); glycine;CHEMBL451140; N'-[N-(2a,3b-Dihydroxy-12-oleanen-28-oyl)-L-alanyl]-glycine; 2-[[(2S)-2-[[(4aS,6aR,6aS,6bR,8aR,10R,11R,12aR,14bS)-10,11-dihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carbonyl]amino]propanoyl]amino]acetic acid;GLY | C2H5NO2 | 75.07 g/mol | C(C(=O)O)N |
| TCMBANKIN058463 | Codopiloic acid | codopiloic acid; codopiloicacid; 136945-75-0; 2H-1,4-oxazine-3-carboxylic acid | C5H5NO3 | 127.1 | C1C(=NC=CO1)C(=O)O |
| TCMBANKIN058589 | 4-Phenylbicyclo[2,2,2]octan-1-ol | 4-phenylbicyclo[2,2,2]octan-1-ol; 4-phenylbicyclo[2.2.2]octan-1-ol | C14H18O | 202.29 | C1CC2(CCC1(CC2)C3=CC=CC=C3)O |
| TCMBANKIN059315 | tangshenoside I | AC1O5UVU; Tangshenoside I; tangshenoside i; 117278-74-7; AK687051; beta-D-Glucopyranoside, 4-(3-(4-carboxy-3-(beta-D-glucopyranosyloxy)-3-methyl-1-oxobutoxy)-1-propenyl)-2,6-dimethoxyphenyl, (S-(E))-; 5-[(E)-3-[3,5-dimethoxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]prop-2-enoxy]-3-methyl-5-oxo-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentanoic acid; AKOS032945999; tangshenoside | C29H42O18 | 678.63 | CC(CC(=O)O)(CC(=O)OCC=CC1=CC(=C(C(=C1)OC)OC2C(C(C(C(O2)CO)O)O)O)OC)OC3C(C(C(C(O3)CO)O)O)O |
| TCMBANKIN059599 | taraxe-rol | C30H50O | 426.7 g/mol | CC1(CCC2(CC=C3C4(CCC5C(C(CCC5(C4CCC3(C2C1)C)C)O)(C)C)C)C)C | |
| TCMBANKIN059820 | atractylenolide iii; codonolactone | C15H20O3 | 248.32 | CC1=C2CC3C(=C)CCCC3(CC2(OC1=O)O)C | |
| TCMBANKIN060140 | friedelan-3-one | C30H50O | 426.7 g/mol | CC1C(=O)CCC2C1(CCC3C2(CCC4(C3(CCC5(C4CC(CC5)(C)C)C)C)C)C)C | |
| TCMBANKIN060679 | stigmasterol | C29H48O | 412.7 g/mol | CCC(C=CC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C | |
| TCMBANKIN060680 | stigmasterol-3-glucoside | C35H58O6 | 574.83 g/mol | CCC(C=CC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C | |
| TCMBANKIN061775 | hibiscetin-heptamethylether | 3,5,7,8,3',4',5'--heptamethoxyflavone | C22H24O9 | 432.4 g/mol | COC1=CC(=CC(=C1OC)OC)C2=C(C(=O)C3=C(O2)C(=C(C=C3OC)OC)OC)OC |
| TCMBANKIN061792 | syringin | C17H24O9; Glucoside, 4-(3-hydroxypropenyl)-2,6-dimethoxyphenyl, D; beta-D-Glucopyranoside, 4-(3-hydroxy-1-propenyl)-2,6-dimethoxyphenyl; LS-172368; Ligustrin (VAN); NSC 287441;syringenone;Syrigin;cis-syringin;ligustrin | C17H24O9 | 372.4 g/mol | COC1=CC(=CC(=C1OC2C(C(C(C(O2)CO)O)O)O)OC)C=CCO |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab